Koninklijke Philips N.V. (Netherlands) and Medtronic (Ireland) are Leading Players in the US Respiratory Care Devices Market
The US respiratory care devices market is projected to reach USD 14.56 billion by 2031 from USD 10.02 billion in 2026, at a CAGR of 7.8% during the forecast period.
The growth of the US respiratory care devices market can be largely attributed to the increasing prevalence of respiratory diseases such as COPD, asthma, and sleep apnea, as well as a rising elderly population that is more susceptible to pulmonary disorders. Additional factors contributing to the rise in diagnosed cases include air pollution, tobacco smoking, and exposure to harmful work environments.
To know about the assumptions considered for the study download the pdf brochure
Recent technological advancements have led to the development of more portable, accurate, and comfortable ventilators, oxygen therapy equipment, and patient monitoring tools for home use, further driving their adoption outside hospital settings. A strong healthcare system, favorable reimbursement policies for respiratory medications, and ongoing product approvals by the US Food and Drug Administration (FDA) for new devices are all contributing to the continued expansion of the market.
Koninklijke Philips N.V., Medtronic, ResMed Inc., Fisher & Paykel Healthcare Limited, and Drägerwerk AG & Co. KGaA are the leading companies in the US respiratory care devices market. Their success is attributed to a wide range of products, advanced technology, and offerings that include ventilators, CPAP/BiPAP systems, oxygen therapy, and respiratory monitoring. These companies are highly focused on research and development, which allows them to continuously innovate and introduce new products, features, and applications. Innovations include connected devices, user-friendly interfaces, and home care solutions.
Their strong presence in the medical field, well-recognized brand names, and solid relationships with US hospitals, sleep labs, and home care providers contribute to customer loyalty and repeat purchases. Additionally, by maintaining tight control over their distribution channels, providing excellent after-sales service, and adhering to stringent US regulatory standards, these companies can efficiently grow, launch new products, and strengthen their leadership positions in a highly competitive and regulated market.
- In December 2025, ResMed received FDA approval for its Smart Comfort feature, which is powered by artificial intelligence. This feature gathers actual sleep data and utilizes machine learning to recommend optimal comfort settings for CPAP therapy tailored to each individual's needs. The Smart Comfort system is a new sleep device that automatically adjusts to the user's requirements. It helps new sleep apnea patients ease into their treatment by determining the best settings that balance pressure and comfort. Additionally, it increases the likelihood that patients will adhere to their treatment over the long term. The launch of the AirSense 11 devices and the myAir app in the US is scheduled for early 2026, and the Smart Comfort feature will be included.
- In April 2025, Drägerwerk AG & Co. KGaA obtained FDA 510(k) clearance for its VentStar Resus heated and VentStar Autobreath heated emergency ventilators. This clearance confirms that these devices are fundamentally similar to other legally marketed devices. With this approval, the company may sell these powered emergency ventilators as Class II devices in the US, provided they comply with general regulatory controls, including labeling, manufacturing quality, and device registration requirement.
Koninklijke Philips N.V. (Netherlands)
Koninklijke Philips N.V. (Philips) is a Dutch multinational health technology company with extensive experience in the global respiratory care device market, including in the US. Through its Sleep & Respiratory Care segment, Philips continuously offers a wide range of respiratory products, such as non-invasive and invasive ventilators, CPAP/BiPAP devices, masks, and home oxygen therapy equipment suitable for both hospital and home use. The company leverages its robust global research and development capabilities and integrates digital platforms, such as Philips HealthSuite, to create connected care solutions that support clinicians and patients throughout the respiratory therapy process. The success of Philips' products can be attributed primarily to their focus on patient comfort, the provision of clinical support services, and the facilitation of healthcare IT systems integration, which ultimately leads to improvements in care quality and patient outcomes. Furthermore, Philips has established a strong market presence through an extensive sales and distribution network in the US, enabling it to serve diverse market segments, including critical care units, sleep laboratories, and home health providers. This broad reach further solidifies Philips' competitive position in the US respiratory care devices market.
Medtronic (Ireland)
Medtronic is a leading global medical technology company that holds a significant share of the US respiratory care devices market, particularly through its portfolio of critical care and surgical technologies. The company manufactures top-tier ventilators, airway management products, and respiratory monitoring instruments that are widely used in intensive care units, emergency departments, and perioperative settings in the US. Medtronic's focus on innovation and clinical validation, along with its strategy for integrating health information technology, allows it to provide advanced remote patient management and care coordination solutions. This is achieved by incorporating Medtronic devices into hospital information systems. Furthermore, Medtronic has a comprehensive distribution and commercial service network in the US, supported by strong clinical partnerships and contracts with prestigious healthcare institutions. This infrastructure enables the company to meet the demand for acute care hospital products and adapt to changing care models, such as telehealth, monitoring, and home respiratory support. By maintaining compliance with regulatory requirements, Medtronic can deliver clinician-oriented products to market quickly. These capabilities will continue to help Medtronic maintain its strong position in the ever-evolving and competitive landscape of US respiratory care devices.
MARKET RANKING
The US respiratory care devices market is primarily dominated by global technology giants and highly specialized respiratory care providers. Koninklijke Philips N.V. and Medtronic are the leading players in this sector. These companies excel at both acute and chronic care levels, capitalizing on their extensive hospital networks, strong critical care portfolios, and advanced offerings in ventilators, oxygen therapy, and monitoring solutions.
ResMed Inc. is a formidable competitor in the US market, particularly in the sleep apnea and home respiratory care segments. This success is largely due to its connected CPAP systems, cloud-based patient monitoring platforms, and a comprehensive home care distribution network.
In addition, Fisher & Paykel Healthcare Limited solidifies its position by providing innovative humidification systems, high-flow nasal cannula devices, and neonatal respiratory solutions, all of which have gained widespread acceptance in US hospitals. Drägerwerk AG & Co. KGaA remains a major player due to its extensive range of emergency and transport ventilators, anesthesia workstations, and ICU-focused respiratory equipment, all supported by exceptional service and training programs.
As a result, the US market has a concentrated supplier base, with only a few technologically advanced multinational companies maintaining a strong brand presence.
Related Reports:
US Respiratory Care Device Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Home Care Settings) - Forecast to 2031
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
